In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

IN VIVO’s Deals Of The Month: April 2016

Executive Summary

IN VIVO’s editors pick April's most significant deals, including DalCor Pharma's big B round and a rash of NASH deals. (Article free with registration.)


Related Content

Deal Watch: NASH In The Hot Seat
Tobira/Dong-A Partnership Will Add DPP-4 Inhibitor For NASH Combo Therapy
Allergan's Back In The (M&A) Saddle Again Post-Pfizer Breakup
Gilead Increases NASH Emphasis With Pickup Of Nimbus ACC Inhibitor


Related Companies

Related Deals




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst